// App-Quantinova.ai

TCT-848 : Percutaneous coronary intervention with Absorb bioresorbable vascular scaffold: major adverse cardiac events, restenosis and device thrombosis after 2-years follow-up. Single center experience in an all-comers population

Researchers

Presenter

  • Antonio de Miguel Castro

Principal Investigators

  • Etelberto Hernandez

  • Victor Jimenez Diaz

  • Alberto Ortiz Saez

  • Guillermo Bastos Fernandez

  • Saleta Fernandez Barbeira

  • Ivan Gomez-Blazquez

  • Jose Baz

  • Andres Iniguez

Medical Centers

  • Complejo Hospital Universitario de Vigo, Vigo, Spain

  • HOSPITAL 12 de Octubre, Madrid, Spain

  • Hospital Alvaro Cunqueiro, Vigo, Spain

  • university of southern california

Locations

  • Spain

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Central Nervous System (CNS)

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Restenosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved